Addition of Mitiglinide to Pioglitazone Monotherapy Improves Overall Glycemic Control in Japanese Patients with Type 2 Diabetes: A Randomized Double Blind Trial

Kohei KAKU; Shun-ichi TANAKA; Hideki ORIGASA; Masatoshi KIKUCHI; Yasuo AKANUMA

doi:10.1507/endocrj.k09e-022

Addition of Mitiglinide to Pioglitazone Monotherapy Improves Overall Glycemic Control in Japanese Patients with Type 2 Diabetes: A Randomized Double Blind Trial

Endocrine Journal ◽

10.1507/endocrj.k09e-022 ◽

2009 ◽

Vol 56 (5) ◽

pp. 657-664 ◽

Cited By ~ 8

Author(s):

Kohei KAKU ◽

Shun-ichi TANAKA ◽

Hideki ORIGASA ◽

Masatoshi KIKUCHI ◽

Yasuo AKANUMA

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Japanese Patients ◽

Double Blind Trial ◽

Double Blind ◽

Blind Trial

Download Full-text

A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)

Diabetes Care ◽

10.2337/diacare.22.6.960 ◽

1999 ◽

Vol 22 (6) ◽

pp. 960-964 ◽

Cited By ~ 317

Author(s):

R. R. Holman ◽

C. A. Cull ◽

R. C. Turner

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Double Blind Trial ◽

Double Blind ◽

Blind Trial

Download Full-text

Glycemic control with Glyburide/Metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: a randomized, double-blind trial

The American Journal of Medicine ◽

10.1016/j.amjmed.2003.07.022 ◽

2004 ◽

Vol 116 (4) ◽

pp. 223-229 ◽

Cited By ~ 78

Author(s):

George E Dailey ◽

Mustafa A Noor ◽

Jong-Soon Park ◽

Simon Bruce ◽

Fred T Fiedorek

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Double Blind Trial ◽

Double Blind ◽

Blind Trial

Download Full-text

Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind trial

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2010.01197.x ◽

2010 ◽

Vol 12 (7) ◽

pp. 613-622 ◽

Cited By ~ 72

Author(s):

Y. Iwamoto ◽

N. Tajima ◽

T. Kadowaki ◽

K. Nonaka ◽

T. Taniguchi ◽

...

Keyword(s):

Type 2 Diabetes ◽

Japanese Patients ◽

Double Blind Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Blind Trial

Download Full-text

Faculty Opinions recommendation of Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725388736.793525626 ◽

2016 ◽

Author(s):

Juan-Carlos Kaski ◽

Amelia Carro

Keyword(s):

Heart Failure ◽

Type 2 Diabetes ◽

Double Blind Trial ◽

Double Blind ◽

Blind Trial

Download Full-text

Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial

The Lancet ◽

10.1016/s0140-6736(14)62225-x ◽

2015 ◽

Vol 385 (9982) ◽

pp. 2067-2076 ◽

Cited By ~ 457

Author(s):

Faiez Zannad ◽

Christopher P Cannon ◽

William C Cushman ◽

George L Bakris ◽

Venu Menon ◽

...

Keyword(s):

Heart Failure ◽

Type 2 Diabetes ◽

Double Blind Trial ◽

Double Blind ◽

Blind Trial

Download Full-text

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

The Lancet ◽

10.1016/s0140-6736(17)30069-7 ◽

2017 ◽

Vol 389 (10077) ◽

pp. 1399-1409 ◽

Cited By ~ 204

Author(s):

Carel W le Roux ◽

Arne Astrup ◽

Ken Fujioka ◽

Frank Greenway ◽

David C W Lau ◽

...

Keyword(s):

Type 2 Diabetes ◽

Risk Reduction ◽

Weight Management ◽

Diabetes Risk ◽

Double Blind Trial ◽

Double Blind ◽

Blind Trial

Download Full-text

Metabolic Effects of Replacing Sucrose by Isomaltulose in Subjects With Type 2 Diabetes: A randomized double-blind trial

Diabetes Care ◽

10.2337/dc11-1485 ◽

2012 ◽

Vol 35 (6) ◽

pp. 1249-1251 ◽

Cited By ~ 22

Author(s):

S. Brunner ◽

I. Holub ◽

S. Theis ◽

A. Gostner ◽

R. Melcher ◽

...

Keyword(s):

Type 2 Diabetes ◽

Metabolic Effects ◽

Double Blind Trial ◽

Double Blind ◽

Blind Trial

Download Full-text

Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial

BMJ ◽

10.1136/bmj.b4324 ◽

2009 ◽

Vol 339 (nov09 1) ◽

pp. b4324-b4324 ◽

Cited By ~ 20

Author(s):

S. S Lund ◽

L. Tarnow ◽

M. Frandsen ◽

B. B Nielsen ◽

B. V Hansen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Obese Patients ◽

Double Blind Trial ◽

Double Blind ◽

Blind Trial ◽

Insulin Secretagogue

Download Full-text

Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial

The Lancet ◽

10.1016/s0140-6736(19)32131-2 ◽

2019 ◽

Vol 394 (10208) ◽

pp. 1519-1529 ◽

Cited By ~ 44

Author(s):

David R Matthews ◽

Päivi M Paldánius ◽

Pieter Proot ◽

YannTong Chiang ◽

Michael Stumvoll ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Double Blind Trial ◽

Newly Diagnosed ◽

Double Blind ◽

Blind Trial ◽

Metformin Monotherapy ◽

Early Combination Therapy

Download Full-text

Efficacy and safety of exenatide as add‐on therapy for patients with type 2 diabetes with an intensive insulin regimen: A randomized double‐blind trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14225 ◽

2020 ◽

Author(s):

Michael Joubert ◽

Victoria Opigez ◽

Barbora Pavlikova ◽

Laure Peyro Saint Paul ◽

Nathalie Jeandidier ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Regimen ◽

Double Blind Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Blind Trial

Download Full-text